-
Innovation Ranking
NewInnovation Ranking – Qiagen NV
Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA, and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life...
-
Company Insights
Innovation and Patenting activity of Qiagen NV Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Qiagen NV Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
NewPCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
PCR Systems Market Report Overview The PCR Systems market size was $700.3 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Polymerase Chain Reaction (PCR) systems are used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. PCR Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the PCR Systems Market Forecast Download a Free...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA Tests market size was $12.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests) are carried out to detect gene rearrangements within blood samples. The outcome of this may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian...
-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BCR-ABL Tests Market Report Overview The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
Mycobacterium Tuberculosis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Mycobacterium Tuberculosis Tests Market Report Overview The Mycobacterium Tuberculosis tests market size was $207.1 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Mycobacterium tuberculosis tests are done to detect active and latent forms of tuberculosis through analysis of sputum samples. Mycobacterium Tuberculosis Tests Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Mycobacterium Tuberculosis Tests Market Forecast Download a Free Report Sample The Mycobacterium Tuberculosis...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BRAF Tests Market Report Overview The BRAF Tests market size was valued at $32.8 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. BRAF Sanger sequencing Tests are used when complete sequencing of the BRAF gene is required for accurate detection and mapping of mutations. Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs). BRAF Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for More...
-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
KRAS Tests Market Report Overview The KRAS tests market size was $80.4 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. Kirsten rat sarcoma virus (KRAS) gene tests are carried out to detect gene mutations in patient tissue samples. The outcome of these tests may guide therapies to treat various cancers including colorectal cancer, certain lung cancers, and some leukemias. KRAS Tests Market Outlook, 2023-2033 ($ Million) Buy the Full Report...
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Report Overview The ALK Tests market size was valued at $27.3 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells, the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for...